NCT04653805View on ClinicalTrials.gov

Therapeutic Approach of Cardiovascular Risk Factors in T2DM by Gender

CompletedOBSERVATIONAL
Enrollment

300,000

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

October 31, 2020

Study Completion Date

May 31, 2022

Conditions
Type 2 DiabetesCardiovascular Risk FactorGender
Interventions
OTHER

Current clinical practice in primary care of patients with type 2 diabetes mellitus

Trial Locations (1)

Unknown

IDIAP Jordi Gol, Barcelona

All Listed Sponsors
lead

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

OTHER

NCT04653805 - Therapeutic Approach of Cardiovascular Risk Factors in T2DM by Gender | Biotech Hunter | Biotech Hunter